Zuogui Nuoyun Tong Jiaonang (左炔诺孕酮胶囊)左炔诺孕酮胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖北葛店人福药业有限责任公司Chinese legal name: 湖北葛店人福药业有限责任公司
主要成分Active Ingredients
- 左炔诺孕酮Zuogui Nuoyun Tong
药物知识说明
左炔诺孕酮是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：左炔诺孕酮Zuogui Nuoyun Tong。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：左炔诺孕酮-e2186390成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 左炔诺孕酮胶囊) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 左炔诺孕酮Zuogui Nuoyun Tong.
Explore other medicines containing the same ingredient: 左炔诺孕酮 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 左炔诺孕酮胶囊Recorded Chinese name: 左炔诺孕酮胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.75mg*2粒0.75 mg × 2 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 湖北葛店人福药业有限责任公司Chinese legal name: 湖北葛店人福药业有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20080243
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20080243
Manufacturer
Chinese legal name: 湖北葛店人福药业有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
0.75 mg × 2 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20080243
生产企业
湖北葛店人福药业有限责任公司(国产)
适应症
本品用于女性紧急避孕，即在无防护措施或其他避孕方法偶然失误时使用。
用法用量
1.口服，在无保护性生活或避孕失败72小时内一次服两粒或在72小时内服第1粒，隔12小时后再服第2粒。 2.服药越早，预防妊娠效果越好。
不良反应
偶有轻度恶心、呕吐，一般不需处理、可自行消失，如症状较重应向医师咨询。
禁忌
1.对本品过敏者禁用。
2.乳腺癌、生殖器官癌，肝功能异常或近期有肝病或黄疸史、静脉血栓病、脑血管意外、高血压、心血管病、糖尿病、高脂血症、精神抑郁症患者及40岁以上妇女禁用。
注意事项
1.本品是用于避孕失误的紧急补救避孕药，不是引产药。
2.本品不宜作为常规避孕药，服药后至下次月经前应采取可靠的避孕措施。
3.如服药后2小时内发生呕吐反应，应立即补服1粒。
4.本品可能使下次月经提前或延期，如逾期1周月经仍未来潮，应即到医院检查，以排除妊娠。
5.本品性状发生改变时禁止使用。
6.请将此药品放在儿童不能接触的地方。
贮藏
遮光，密封保存。
规格
0.75mg*2粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.